Review connects pharmaceutical 3D printing to colloidal behavior and evidence gaps
Academic source · Current Opinion in Colloid & Interface Science
Source published: · Event / reporting date: 2026-11-03
Site published: 2026-11-08 · Updated: 2026-11-08
This source is linked automatically. Choose a question to get started.
What the paper reports
A review examines pharmaceutical additive manufacturing through rheology, gelation, wetting, and material stability. It distinguishes printable formulations from stimulus-responsive and history-dependent adaptive systems, and proposes minimum reporting requirements. The authors identify limited in vivo evidence, inconsistent ink reproducibility, and unresolved regulatory pathways for shape-changing products. This summary is based on the journal abstract.
Why this paper is included
Potential business implication: formulation teams may use the framework to define reproducibility and characterization requirements before advancing printed dosage forms.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections